Life-Saving
Diagnostic Solutions

FOR A HEALTHIER TOMORROW

GROUND-BREAKING DIAGNOSTICS IN DEVELOPMENT

Learn More

AUTOMATED LAB SOLUTIONS TO MAXIMIZE TESTING

Watch Now

LARGE VOLUME COVID-19 TESTING FOR CLIA LABS

Read More

Diagnostic Testing Solutions for the Immune System

COVID, Cancer & Alzheimer’s

Lab Solutions

Our focus on automation has created a commercial infrastructure able to deploy integrated solutions for labs looking to scale services for their core clients.

Provista Diagnostics: CLIA/CAP Lab >
COVID Testing Solutions >

R&D Pipeline

Evidence suggests that blood-based tests are the future of cancer screening. Our TBIA platform represents a cost-effective, scalable, and patient-friendly screening practice for cancer detection.

Videssa® Breast: Cancer Blood Test >
LymPro™: Alzheimer's Blood Test >
TolloTest™: 3CL Protease Test >
TBIA: AI Cancer Platform >

 

Protease Inhibitors

Todos has acquired exclusive distribution rights to the immune boosting, dietary supplement Tollovid™ and is developing Tollovir™, a highly potent 3CL protease inhibitor as a COVID-19 antiviral.

Antiviral Drug Development >
Dietary Supplement >

Meet Our Partners

harvard_logo leipzig_logo 3dmed_logo asu2_logo meridan_logo osang_logo Fosun_logo nlc-pharma_logo
Todos Medical TOMDF Corporate Presentation EMERGING GROWTH - APRIL 2021

Download the 2021 Todos Medical Investor Package

Stay informed of our latest breakthroughs.